- Towards responsible use of cognitive-enhancing drugs by the healthy.Henry Greely, Barbara Sahakian, John Harris, Ronald Kessler, Gazzaniga C., Campbell Michael, Farah Philip & J. Martha - 2008 - Nature 456:702-705.details
|
|
Normal Functioning and the Treatment-Enhancement Distinction.Norman Daniels - 2000 - Cambridge Quarterly of Healthcare Ethics 9 (3):309--322.details
|
|
Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW]Nick Bostrom - 2009 - Science and Engineering Ethics 15 (3):311-341.details
|
|
The inevitability of genetic enhancement technologies.Francoise Baylis & Jason Scott Robert - 2004 - Bioethics 18 (1):1–26.details
|
|
The future of psychopharmacological enhancements: Expectations and policies.Maartje Schermer, Ineke Bolt, Reinoud de Jongh & Berend Olivier - 2009 - Neuroethics 2 (2):75-87.details
|
|
Cognitive enhancement, lifestyle choice or misuse of prescription drugs?Eric Racine & Cynthia Forlini - 2008 - Neuroethics 3 (1):1-4.details
|
|
Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.V. Cakic - 2009 - Journal of Medical Ethics 35 (10):611-615.details
|
|
“Doctor, Would You Prescribe a Pill to Help Me …?” A National Survey of Physicians on Using Medicine for Human Enhancement.Matthew K. Wynia, Emily E. Anderson, Kavita Shah & Timothy D. Hotze - 2011 - American Journal of Bioethics 11 (1):3 - 13.details
|
|
The use of methylphenidate among students: the future of enhancement?S. M. Outram - 2010 - Journal of Medical Ethics 36 (4):198-202.details
|
|
The promise and predicament of cosmetic neurology.Anjan Chatterjee - 2006 - Journal of Medical Ethics 32 (2):110-113.details
|
|
The Inevitability of Genetic Enhancement Technologies.FranÇoise Baylis & Jason Scott Robert - 2004 - Bioethics 18 (1):1-26.details
|
|
Autonomy and coercion in academic “cognitive enhancement” using methylphenidate: Perspectives of key stakeholders. [REVIEW]Cynthia Forlini & Eric Racine - 2009 - Neuroethics 2 (3):163-177.details
|
|
The Future of Psychopharmacological Enhancements: Expectations and Policies.M. H. N. Schermer, I. Bolt, R. De Jongh & B. Olivier - 2009 - Neuroethics 2 (2):75-87.details
|
|